Evidence map›Paper›PMID 30037058›Full record

ReviewGenes2018

Adaptation and Therapeutic Exploitation of the Plasma Membrane of African Trypanosomes.

Juan F Quintana, Ricardo Canavate Del Pino, Kayo Yamada, Ning Zhang

Abstract readReview
In one paragraph

Review in Genes, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Drug resistance in animal trypanosomiases: Epidemiology, mechanisms and control strategies.International journal for parasitology. Drugs and drug resistance · 2024
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. An Overview of Drug Resistance in Protozoal Diseases.International journal of molecular sciences · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Juan F QuintanaSchool of Life Sciences, University of Dundee, Dow Street, Dundee, DD1 5EH, UK. j.f.z.quintanaalcala@dundee.ac.uk.ORCID 0000-0002-5092-5576
Ricardo Canavate Del PinoSchool of Life Sciences, University of Dundee, Dow Street, Dundee, DD1 5EH, UK. r.canavatedelpino@dundee.ac.uk.
Kayo YamadaSchool of Life Sciences, University of Dundee, Dow Street, Dundee, DD1 5EH, UK. k.ono@dundee.ac.uk.
Ning ZhangSchool of Life Sciences, University of Dundee, Dow Street, Dundee, DD1 5EH, UK. mfield@mac.com.ORCID 0000-0002-4866-2885

Funding

Medical Research Council MR/N010558/1Medical Research Council MR/P009018/1Wellcome Trust 203134/Z/16/Z
6 · The paper itself

Abstract

African trypanosomes are highly divergent from their metazoan hosts, and as part of adaptation to a parasitic life style have developed a unique endomembrane system. The key virulence mechanism of many pathogens is successful immune evasion, to enable survival within a host, a feature that requires both genetic events and membrane transport mechanisms in African trypanosomes. Intracellular trafficking not only plays a role in immune evasion, but also in homeostasis of intracellular and extracellular compartments and interactions with the environment. Significantly, historical and recent work has unraveled some of the connections between these processes and highlighted how immune evasion mechanisms that are associated with adaptations to membrane trafficking may have, paradoxically, provided specific sensitivity to drugs. Here, we explore these advances in understanding the membrane composition of the trypanosome plasma membrane and organelles and provide a perspective for how transport could be exploited for therapeutic purposes.

Indexed as

drug developmentendocytosisendomembrane systemnanobodiessurface proteomeTrypanosoma brucei

Identifiers

PMID30037058
PMCPMC6071061

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.